Why is Samrat Pharma falling/rising?

As of 29-Oct, Samrat Pharmachem Ltd's stock price is currently at 299.95, reflecting an increase of 23.0, or 8.3%. The stock has shown a trend reversal today, gaining after two consecutive days of decline. Despite opening with a loss of 2.11%, it reached an intraday high of Rs 307.5, indicating significant volatility with a wide trading range of Rs 36.4. The stock's performance today has outperformed its sector by 7.56%, and there has been a notable increase in investor participation, with delivery volume rising by 126.12% compared to the 5-day average. However, the stock has faced challenges in the longer term, with a year-to-date decline of 21.49% and a one-year drop of 32.75%.
In the broader market context, the Sensex has shown a positive return of 5.76% over the past month, contrasting with Samrat Pharmachem's modest gain of 0.99% in the same period. This indicates that while the stock is experiencing a short-term rebound, it has significantly underperformed compared to the benchmark over the longer term. The stock's current price movement suggests a potential recovery, but its historical performance raises concerns about sustainability, especially given its substantial declines over the past year and three years.